Elagolix Completed Phase 2 Trials for Heavy Uterine Bleeding / Uterine Leiomyomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01817530Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
NCT01441635Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids